It is converted from glutamic acid by the action of glutamic acid decarboxylase (GAD).
What does GAD stand for?
GAD stands for Glutamic Acid Decarboxylase
This definition appears very frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other definitions of GAD
We have 132 other meanings of GAD in our Acronym Attic
- Genesys Agent Desktop (customer contact center industry)
- Geocentric Axial Dipole (physics)
- Georgia Association of the Deaf, Inc.
- Germersheim Army Depot
- Gesellschaft für Automatische Datenverarbeitung (German: EDP society)
- Gift Aid Declaration (charitable contributions; UK)
- Global Account Director (various companies)
- Global Active Directory (Microsoft)
- Global Application Delivery
- Globalization and Democracy
- Go and Die (texting)
- Government Actuary's Department (UK)
- Government Administration and Defence (Australia)
- Government Affairs Division (various organizations)
- Grants Administration Division
- Growth and Development
- Guard Capacity Adaptation Based on Dropping
- Glutamic Acid Decarboxylase-Immunoreactive
- Glutamic Acid Decarboxylase 2
- Glutamic Acid Decarboxylase 65-kDa
Samples in periodicals archive:
In this case, the glutamic acid decarboxylase (GAD) gene was employed because GAD makes a chemical called GABA, a major inhibitory neuro-transmitter in the brain that helps "quiet" excessive neuronal firing related to Parkinson's disease.
8% proved to be positive for glutamic acid decarboxylase (GAD)-65 and/or insulino-ma-associated protein 2 autoantibodies.
Direct infusion of the gene for glutamic acid decarboxylase into the subthalamic nucleus of patients with Parkinson's disease significantly improved measures of motor function, compared with patients who underwent a sham procedure, according to the results of a phase II trial in 45 patients.
Kaplitt used the virus to deliver glutamic acid decarboxylase (GAD), the enzyme that synthesizes the neurotransmitter GABA.
IA was defined as being positive in two or more measurements of autoantibodies indicative of the autoimmune response: glutamic acid decarboxylase (GADA); tyrosine phosphatase (IA-2A); insulin autoantibodies (IAA) analysed at the three time points or being diagnosed with type 1 diabetes during the 5 year follow up period.
The appearance of autoantibodies to (3-cell antigens, such as insulin, the 65-kDa isoform of glutamic acid decarboxylase (GAD65)', and protein tyrosine phosphatase-like molecule (IA-2), into the peripheral circulation predicts clinical disease, and the presence of multiple autoantibodies and IA-2 autoantibodies JA2-As) indicates high probability that the disease will appear soon (1, 2).